Summary
Matrix metalloproteinases (MMPs) have been implicated as important factors in gliomas since they may both facilitate invasion into the surrounding brain and participate in neovascularization. We have tested the hypothesis that deregulated expression of gelatinase-A or B, or an activator of gelatinase-A, MT1-MMP, may contribute directly to human gliomas by quantifying the expression of these MMPs in 46 brain tumour specimens and seven control tissues. Quantitative RT-PCR and gelatin zymography showed that gelatinase-A in glioma specimens was higher than in normal tissue; these were significantly elevated in low grade gliomas and remained elevated in GBMs. Gelatinase-B transcript and activity levels were also higher than in normal brain and more strongly correlated with tumour grade. We did not see a close relationship between the levels of expression of MT1-MMP mRNA and amounts of activated gelatinase-A. In situ hybridization localized gelatinase-A and MT1-MMP transcripts to normal neuronal and glia, malignant glioma cells and blood vessels. In contrast, gelatinase-B showed a more restricted pattern of expression; it was strongly expressed in blood vessels at proliferating margins, as well as tumour cells in some cases. These data suggest that gelatinase-A, -B and MT1-MMP are important in the pathophysiology of human gliomas. The primary role of gelatinase-B may lie in remodelling associated with neovascularization, whereas gelatinase-A and MT1-MMP may be involved in both glial invasion and angiogenesis.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Apodaca, G., Rutka, J. T., Bouhana, K., Berens, M. E., Giblin, J. R., Rosenblum, M. L., McKerrow, J. H. & Banda, M. J. (1990). Expression of metalloproteinase and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50: 2322–2329.
Aznavoorian, S., Murphy, A. N., Stetler-Stevenson, W. G. & Liotta, L. A. (1993). Molecular aspects of tumor cell invasion and metastasis. Cancer 71: 1368–1383.
Azzam, H. S., Arand, G., Lippman, M. E. & Thompson, W. E. (1993). Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85: 1758–1754.
Bendeck, M. P., Irvin, C. & Reidy, M. A. (1996). Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 78: 38–43.
Bernhard, E. J., Gruber, S. B. & Muschel, R. J. (1994). Direct evidence linking expression of matrix metalloproteinase 9 (92 kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat cells. Proc Natl Acad Sci USA 91: 4293–4297.
Brown, P. D., Bloxidge, R. E., Stuart, N. S., Gatter, K. C. & Carmichael, J. (1993). Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small cell lung carcinoma. J Natl Cancer Inst 85: 574–579.
Burger, P. C., Dubois, P. J., Schold, S. C. Jr, Smith, K. R. Jr, Odom, G. L., Crafts, D. C. & Giangaspero, F. (1983). Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58: 159–169.
Butler, G. S., Will, H., Atkinson, S. J. & Murphy, G. (1997). Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Eur J Biochem 244: 653–657.
Cornelius, L. A., Nehring, L. C., Roby, J. D., Parks, W. C. & Welgus, H. G. (1995). Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J Invest Dermatol 105: 170–176.
Costello, P. C., Del Maestro, R. F. & Stetler-Stevenson, W. G. (1994). Gelatinase A expression in human malignant gliomas. Ann NY Acad Sci 732: 450–452.
Davies, B., Waxman, J., Wasan, H., Abel, P., Williams, G., Krausz, T., Neal, D., Thomas, D., Hanby, A. & Balkwill, F. (1993). Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365–5369.
Edwards, D. R., Beaudry, P. P., Laing, T. D., Kowal, V., Leco, K. J. & Lim, M. S. (1996). The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obesity 20: S9–S15.
Foda, H. D., George, S., Conner, C., Drews, M., Tompkins, D. C. & Zucker, S. (1996). Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. Lab Invest 74: 538–545.
Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182–1186.
Forsyth, P. A., Dickinson-Laing, T., Gibson, A. W., Rewcastle, N. B., Brasher, P., Sutherland, G., Johnston, R. N. & Edwards, D. R. (1998). High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma. J Neurooncol 36: 21–29.
Giese, A. & Westphal, M. (1996). Glioma invasion in the central nervous system. Neurosurgery 39: 235–252.
Haddad, S. F., Moore, S. A., Schelper, R. L. & Goeken, J. A. (1992). Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme. J Neuropathol Exp Neurol 51: 488–492.
Hanahan, D. & Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353–364.
Hanemaaijer, R., Koolwijk, Le Clerc, Q. L., De Vree, W. J. A. & Van Hinsbergh, V. W. M. (1993). Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor α, interleukin 1 and phorbol ester. Biochem J 296: 803–809.
Heppner, K. J., Matrisian, L. M., Jensen, R. A. & Rodgers, W. H. (1996). Expression of most MMP family members in breast cancer represents a tumor-induced host response. Am J Pathol 149: 273–282.
Hirschi, K. K. & D’Amore, P. (1996). Pericytes in the microvasculature. Cardiovasc Res 32: 687–698.
Johnson, M. D., Kim, H. R., Chesler, L., Tsao, Wu-G, Bouck, N. & Polverini, P. J. (1994). Inhibition of angiogenesis by TIMP. J Cell Physiol 160: 194–202.
Kelly, P. J., Daumas-Duport, C., Scheithauer, B. W., Kall, B. A. & Kispert, D. B. (1987). Stereotactic histologic correlations of computed tomography and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clinic Proc 62: 450–459.
Leco, K. J., Apte, S. S., Taniguchi, G. T., Hawkes, S. P., Khokha, R., Schultz, G. A. & Edwards, D. R. (1997). Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues. FEBS Letts 401: 213–217.
Lewalle, J. M., Munaut, C., Pichot, B., Cataldo, D., Baramova, E. & Foidart, J. M. (1995). Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. J Cell Physiol 165: 475–483.
Mignatti, P. & Rifkin, D. B. (1993). Biology and chemistry of proteinases in tumor invasion. Physiol Rev 73: 161–185.
Murphy, G. & Knauper, V. (1997). Relating matrix metalloproteinase structure to function: Why the ‘Hemopexin’ domain?. Matrix Biol 15: 511–518.
Nakagawa, T., Kubota, T., Kabuto, M., Sato, K., Kawano, H., Hayakawa, T. & Okada, Y. (1994). Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69–77.
Nakagawa, T., Kubota, T., Kabuto, M., Fujimoto, N. & Okada, Y. (1996). Secretion of matrix metalloproteinases-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix. J Neurooncol 28: 13–24.
Nakano, A., Tani, E., Miyazaki, K., Yamamoto, Y. & Furuyama, J. (1995). Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298–307.
Nakano, A., Tani, E., Miyazaki, K., Furuyama, J. & Matsumoto, T. (1993). Expressions of matrilysin and stromelysin in human glioma cells. Biochem Biophys Res Commun 192: 999–1003.
Pendas, A. M., Knauper, V., Puente, X. S., Llano, E., Mattei, M-G, Apte, S., Murphy, G. & Lopez-Otin, C. (1997). Identification and characterization of a novel human matrix metalloproteinase and unique structural characteristics, chromosomal location and tissue distribution. J Biol Chem 272: 4281–4286.
Poulsom, R., Hanby, A. M., Pignatelli, M., Jeffrey, R. E., Longcroft, J. M., Rogers, L. & Stamp, G. W. H. (1993). Expression of gelatinase-A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 46: 429–436.
Puente, X. S., Pendas, A. M., Llano, E., Velasco, G. & Lopez-Otin, C. (1996). Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56: 944–949.
Pyke, C., Ralfkiaer, E., Tryggvason, K. & Dano, K. (1993). Messenger RNA for two types of type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 142: 359–365.
Rao, J. S., Steck, P. A., Mohanam, S., Stetler-Stevenson, W. G., Liotta, L. A. & Sawaya, R. (1993). Elevated levels of Mr 92000 type IV collagenase in human brain tumors. Cancer Res 53: 2208–2211.
Rao, J. S., Yamamoto, M., Mohaman, S., Gokaslan, Z. L., Stetler-Stevenson, W. G., Rao, V. H., Fuller, G. N., Liotta, L. A., Nicolson, G. L. & Sawaya, R. E. (1996). Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin Exp Metastasis 14: 12–18.
Rosenthal, R. A., Moses, M. A., Shintani, Y., Megyesi, J. F., Langer, R. & Folkman, J. (1994). Purification and characterization of two collagenase inhibitors from mouse sarcoma 180 conditioned medium. J Cell Biochem 56: 97–105.
Rutka, J. T., Matsuzawa, K., Hubbard, S. L., et al (1995). Expression of TIMP-1, TIMP-2, 72- and 92-kDa type IV collagenase transcripts in human astrocytoma cell lines: correlation with astrocytoma cell invasiveness. Int J Oncol 6: 877–884.
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. & Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61–65.
Sawaya, R. E., Yamamoto, M., Gokaslan, Z. L., Wang, S. W., Mohanam, S., Fuller, G. N., McCutcheon, I. E., Stetler-Stevenson, W. G., Nicolson, G. L. & Rao, J. S. (1996). Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 14: 35–42.
Saxena, A., Robertson, J. T. & Kufta, C. (1995). Increased expression of gelatinase A and TIMP-2 in primary human glioblastomas. Int J Oncol 7: 469–473.
Schnaper, H. W., Grant, D. S., Stetler-Stevenson, W. G., Fridman, R., D’Orazi, C., Murphy, A. N., Bird, R. E., Hoythya, M., Fuerst, T. R., French, D. L., Quigley, J. P. & Kleinman, H. K. (1993). Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 156: 235–246.
Taraboletti, G., Garofalo, A., Belotti, D., Drudis, T., Borsotti, P., Scanziani, E., Brown, P. D. & Giavazzi, R. (1995). Inhibition of angiogenesis and murine hemangioma growth by Batimasatat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst 87: 293–298.
Thorgeirsson, U. P., Yoshiji, H., Sinha, C. C. & Gomez, D. E. (1996). Breast cancer; tumor neovasculature and the effect of TIMP-1 on angiogenesis. In vivo 10: 137–144.
Ueno, H., Nakamura, H., Inoue, M., Imai, K., Noguchi, M., Sato, H., Seiki, M. & Okada, Y. (1997). Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 57: 2055–2060.
Uhm, J. H., Dooley, N. P., Villemure, J-G & Yong, V. W. (1996). Glioma invasion in vitro: regulation by matrix metalloproteinase-2 and protein kinase C. Clin Exp Metastasis 14: 421–433.
Urbanski, S. J., Edwards, D. R., Maitland, A., Leco, K. J., Watson, A. & Kossakowska, A. E. (1992). Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 66: 1188–1194.
Wesseling, P., Schlingemann, R. O., Rietveld, F. J. R., Link, M., Burger, P. C. & Ruiter, D. J. (1995). Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study. J Neuropathol Exp Neurol 54: 304–310.
Woessner, J. F. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 5: 2145–2154.
Wong, H., Anderson, W. D., Cheng, T. & Riabowol, K. T. (1994). Monitoring mRNA expression by polymerase chain reaction: the ‘primer-dropping’ method. Anal Biochem 223: 251–258.
Yamamoto, M., Mohanam, S., Sawaya, R., Fuller, G. N., Seiki, M., Sato, H., Gokaslan, Z. L., Liotta, L. A., Nicolson, G. L. & Rao, J. S. (1996). Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase-A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56: 384–392.
Yong, V. W., Krekowski, C. A., Forsyth, P. A., Bell, R. & Edwards, D. (1998). Matrix Metalloproteinases and diseases of the CNS. Trends Neurosci 21: 75–80.
Zucker, S., Cponner, C., DiMassmo, B. I., Ende, H., Drews, M., Seiki, M. & Bahou, W. F. (1995). Thrombin induces the activation of progelatinase A in vascular endothelial cells. J Biol Chem 270: 23730–23738.
Author information
Authors and Affiliations
Additional information
Community Health Sciences, The University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Forsyth, P., Wong, H., Laing, T. et al. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79, 1828–1835 (1999). https://doi.org/10.1038/sj.bjc.6990291
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6990291